Analysis for small-for-size liver transplantation ; strategy for safety living donorl liver transplantation in adult
Analysis for small-for-size liver transplantation ; strategy for safety living donorl liver transplantation in adult
批准号:
10470250
负责人:
FURUKAWA Hiroyuki
金额:
$8.26万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
To investigate pathophisiology and treatment of small-for-size liver transplantation, we performed experimental and clinical studies.To investigate minimum limit of liver volume, 85% hepatectomy was performed in mice, rats, beagle dogs. These study revealed that massive hepatectomy induce TNF-α mRNA up-regulaton, increase endothelin-1 production, and augment portal vein pressure in mice, rats, and dogs, respectively. In mice experiment, TNF-a inhibitors, ONO-SM362, and TNF-α monoclonal antibody, prolonged animal survival significantly compared to untreated control. Real time PCR analysis has revealed that TNF-α mRNA expression in liver tissue was suppressed significantly by ONO-SM362 at 24hr after 85% hepatectomy. A non-selective endothelin recptor antagonist, TAK-044, was administered into 85% hepatectomized rats before surgery. The treated rats survived more than 2weeks, although the untreated rats died within 24hr after surgery. In canine experiments, although TAK-044, and another k … More ind of vasodilator, PDE III inhibitor including amrinone and milrinone, and port-caval shunt suppressed portal vein pressure and prolonged animal survival, the treatments did not get long survival more than 2weeks except one dog treated with TAK-044, which is still alive even 2year after the massive hepatectomy. Taking all things mentioned above into account, TNF-α inhibitors and vasodilators are effective for liver failure after massive hepatectomy, but further experiments are necessary to get long survivor in canine 85% hepatectomy.In clinical study, graft volume and hepatic blood flows were measured, and they were evaluated on the view point of patients prognosis after adult living donor liver transplantation (LDLT). When the portal venous flow reached the range from 150 to 250 (ml/min 100 g liver graft) after revascularization, the patients experienced fewer complications. The portal blood range correlated to over 40% graft versus standard liver volume (GV/SV) ratio. According to this clinical analysis, we recommend right lobe graft in adult LDLT, if conditions of donor are permissive. Less
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Fujita M, Nagashima K: "Sequential observation of liver cell regeneration after massive hepatic necrosis in auxiliary partial orthotopic liver transplantation (APOLT)."Modern Pathology. 13(2). 152-157 (2000)
Fujita M,Nagashima K:“辅助部分原位肝移植(APOLT)中大量肝坏死后肝细胞再生的顺序观察。”现代病理学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K Ogata: "ATTENUATION OF ISCHEMIA AND REPERFUSION INJURY OF CANINE LIVERS BY INHIBITION OF TYPE II PHOSPHOLIPASE A_2 WITH LY329722."Transplantation. (in press).
K Ogata:“通过使用 LY329722 抑制 II 型磷脂酶 A_2 来减轻犬肝脏缺血和再灌注损伤。”移植。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Furukawa: "What is the limit of the graft size for successful living donor liver transplantation in adults?"Transplantation Proceedings. (in press).
H.Furukawa:“成人活体肝移植成功的移植物大小的限制是多少?”移植论文集。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
松下通明: "肝移植と胆汁うっ滞・生体肝移植後高ビリルビン血症と small-for-size graft との関連の観点から"胆と膵. 21(8). 661-666 (2000)
Michiaki Matsushita:“从活体肝移植后高胆红素血症和小尺寸移植物之间关系的角度来看,肝移植和胆汁淤积”,Bile and Pancreas 21(8) 661-666。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kawasaki S: "First case of cadaveric liver transplantation in Japan."Journal of Hepatobiliary Pancreat Surgery. 6. 387-390 (1999)
川崎S:“日本首例尸体肝移植。”肝胆胰外科杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
High precision determination of intraocular lens power using whole eye segment OCT
-
批准号:26350512
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2014
-
负责人:FURUKAWA Hiroyuki
-
依托单位:
Development of perfusion preservation method of liver graft, aiming to clinical application for liver transplantation using non-heart-beating-donor
-
批准号:23659608
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:FURUKAWA Hiroyuki
-
依托单位:
Polarization analysis of age-related changes of the crystalline lens with high sensitivity OCT
-
批准号:23500529
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:FURUKAWA Hiroyuki
-
依托单位:
Development of a gene therapy based new strategy in small bowel transplantation
-
批准号:16390368
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.09万
-
财政年份:2004
-
负责人:FURUKAWA Hiroyuki
-
依托单位:
The induction of tolerance using the brand new gene therapy in transplantation setting and clarification of the mechanism.
-
批准号:13470248
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:2001
-
负责人:FURUKAWA Hiroyuki
-
依托单位:
Development of safety methods for adult to adult living donor liver transplantation focused on cyclic AMP signal pathway.
-
批准号:13557102
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.77万
-
财政年份:2001
-
负责人:FURUKAWA Hiroyuki
-
依托单位:
Research on Practical Techniques of Laser Cleaning for Decontaminated Surface of Nuclear Facility
-
批准号:10558080
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$6.08万
-
财政年份:1998
-
负责人:FURUKAWA Hiroyuki
-
依托单位:
Study of the cholesterol transportation mechanism in embryo
-
批准号:09671672
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1997
-
负责人:FURUKAWA Hiroyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TNF-a协同IL-6通过内质网应激上调中性粒细胞上LOX1表达诱导HBV-ACLF患者细菌感染的作用机制研究
-
批准号:2023J01239
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:余雪平
-
依托单位:
TNF-a通过MICA/ULBP2双向干预OA软骨衰老细胞免疫逃逸的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:顾延庆
-
依托单位:
TNF-a调控Tfh细胞分化在老年衰弱发生发展中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:倪进东
-
依托单位:
哌啶酸通过促进TNF-a分泌介导溃疡性结肠炎发生的机制研究
-
批准号:82100540
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘蓉蓓
-
依托单位:
TNF-a通过调控lncRNA-SNHG1/G3BP1/USP10蛋白复合体促进IL-6自分泌参与肝癌进展的机制研究
-
批准号:82072714
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:商昌珍
-
依托单位:
基于NF-κB/TNF-a介导的炎症信号通路探讨皮下埋植孕激素致子宫内膜崩解过程的分子机制
-
批准号:81971434
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2019
-
负责人:李云峰
-
依托单位:
搭载TNF-a的壳聚糖缓释系统的阻滞效应治疗先天性半椎体的研究
-
批准号:81960413
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2019
-
负责人:王迎松
-
依托单位:
TNF-a调控lncRNA-UTHC/NF-κB正反馈环路促进肝癌索拉非尼耐药的机制研究
-
批准号:81672419
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:陈亚进
-
依托单位:
TNF-a通过HuR上调TRAF1表达的机制及作用研究
-
批准号:81400128
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨林
-
依托单位:
复合TNF-a siRNA INH RFP纳米骨局部治疗脊柱结核的实验研究
-
批准号:81460335
-
项目类别:地区科学基金项目
-
资助金额:48.0万元
-
批准年份:2014
-
负责人:戈朝晖
-
依托单位: